Human CD10/MME HEK293T Stable Cell Line

Introduction

The Human CD10/MME HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the human CD10 protein. CD10, also known as membrane metallo-endopeptidase (MME), is a cell surface protein that plays a crucial role in various physiological processes, including cell growth and differentiation, immune response, and tissue remodeling. In this article, we will provide a comprehensive overview of the Human CD10/MME HEK293T Stable Cell Line, highlighting its structure, activity, and potential applications in the field of therapeutics.

Structure of Human CD10/MME

The Human CD10/MME HEK293T Stable Cell Line is derived from the human embryonic kidney cell line HEK293T, which is widely used in biomedical research due to its high transfection efficiency and ability to produce large amounts of recombinant proteins. The stable cell line is engineered to express the full-length human CD10 protein, which consists of 1006 amino acids and has a molecular weight of approximately 110 kDa. CD10 is a type II transmembrane protein, with a large extracellular domain containing a zinc-binding motif and a short cytoplasmic tail. The extracellular domain of CD10 is responsible for its enzymatic activity, while the cytoplasmic tail is involved in intracellular signaling and protein-protein interactions.

Activity of Human CD10/MME

The primary function of CD10 is to cleave peptide bonds in various proteins, including cytokines, chemokines, and growth factors. This activity is mediated by the zinc-binding motif in the extracellular domain of CD10, which acts as a metalloprotease. CD10 is known to cleave a wide range of substrates, and its activity is regulated by various factors, such as pH, temperature, and the presence of inhibitors. In addition to its enzymatic activity, CD10 also plays a role in cell signaling and adhesion, as well as modulating the activity of other proteins through proteolytic processing.

Applications of Human CD10/MME HEK293T Stable Cell Line

The Human CD10/MME HEK293T Stable Cell Line has numerous potential applications in the field of therapeutics. One of the main uses of this cell line is in drug discovery and development, as CD10 is considered a promising therapeutic target for various diseases, including cancer, inflammatory disorders, and neurodegenerative diseases. The stable cell line can be used to screen potential inhibitors or activators of CD10 activity, which could lead to the development of novel treatments for these conditions.
Another potential application of the Human CD10/MME HEK293T Stable Cell Line is in the study of CD10-related diseases. Mutations in the CD10 gene have been linked to various disorders, such as Alzheimer’s disease, chronic lymphocytic leukemia, and autism spectrum disorder. By using this stable cell line, researchers can investigate the effects of these mutations on CD10 activity and its downstream signaling pathways, providing valuable insights into the pathogenesis of these diseases.
Furthermore, the Human CD10/MME HEK293T Stable Cell Line can be used in basic research to study the role of CD10 in various cellular processes. For example, flow cytometry analysis can be performed on the stable cell line to assess the expression and activity of CD10 under different conditions, providing a better understanding of its function in normal and disease states.

Conclusion

The Human CD10/MME HEK293T Stable Cell Line is a powerful tool for studying the structure, activity, and potential therapeutic applications of the human CD10 protein. Its stable expression of full-length CD10 allows for reliable and reproducible results, making it an ideal model for drug discovery, disease research, and basic scientific investigations.